Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RNAi
RNAi
RNAi company Dicerna raises $100M follow-on
BioCentury
Fri, 09/7/18 - 05:47 pm
Dicerna Pharmaceuticals
RNAi
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
Xconomy
Thu, 08/30/18 - 10:20 am
RNAi
Alynylam
Europe
Onpattro
hATTR
Patisiran
Sirnaomics cleared to start first trial of RNAi lead in cancer
Fierce Biotech
Sat, 08/18/18 - 05:14 pm
gene silencing
Simaomics
RNAi
STP705
3 Hurdles Ahead of Alnylam and Its Revolutionary New Drug
Motley Fool
Wed, 08/15/18 - 10:13 pm
Alnylam
Onpattro
RNAi
After Alnylam’s solo maiden launch, here comes the tricky bit
EP Vantage
Tue, 08/14/18 - 12:06 am
Alnylam
drug launches
FDA
RNAi
Patisiran
Onpattro
In first, FDA approves RNA interference drug from Alnylam
Biopharma Dive
Fri, 08/10/18 - 02:25 pm
Alnylam
RNAi
FDA
Patisiran
Onpattro
hATTR amyloidosis
With patisiran launch in its sights, Alnylam plots a major hiring spree
Fierce Pharma
Tue, 08/7/18 - 12:02 pm
Alnylam
Patisiran
RNAi
hirings
Focused on rebuilding the pipeline, Axovant’s new crew assembles another preclinical gene therapy deal
Endpoints
Mon, 07/9/18 - 10:55 am
Axovant Sciences
AXO-Lenti-PD
gene therapy
RNAi
Benitec
Poised to launch its first marketing effort, Alnylam makes a big leap into CNS diseases and Alzheimer’s
Endpoints
Tue, 05/8/18 - 08:22 pm
Alnylam
RNAi
Alzheimer's disease
Alnylam Starts Rolling NDA Submission for RNAi Candidate
Yahoo/Zacks.com
Fri, 11/17/17 - 11:15 am
Alnylam
RNAi
hereditary ATTR amyloidosis
FDA
Patisiran
Alnylam outshines Ionis with RNAi drug
BioPharma Dive
Sat, 11/4/17 - 08:40 am
Alnylam
Ionis Pharmaceuticals
RNAi
Sanofi
Patisiran
amyloidosis
Dicerna and Boehringer partner on RNAi treatment for NASH
Endpoints
Thu, 11/2/17 - 11:14 am
Dicerna
Boehringer Ingelheim
NASH
RNAi
A drug 15 years in the making: Alnylam's quest to prove RNAi
BioPharma Dive
Sat, 09/30/17 - 10:16 am
Alnylam
RNAi
Patisiran
Alnylam’s rare disease drug shines in trial, paving way for a brand-new class of medicines
Stat
Wed, 09/20/17 - 09:27 am
Alnylam
rare disease
Patisiran
familial amyloid polyneuropathy
RNAi
Alnylam review turns up no clear answers on revusiran deaths
BioPharma Dive
Thu, 08/10/17 - 06:53 pm
Alnylam
revusiran
RNAi
EuroBiotech Report: Brexit, BioNTech success, GlaxoSmithKline inks AI deal, Silence takes Alnylam to court and Shire makes cuts
Fierce Biotech
Thu, 07/6/17 - 05:58 pm
Europe
biotech
Brexit
BioNTech
GSK
artificial intelligence
Sanofi
Exscientia
Silence Therapeutics
RNAi
Alnylam lines up Phase 3 for another RNAi drug
BioPharma Dive
Tue, 06/27/17 - 10:33 am
Alnylam
RNAi
givosiran
acute hepatic porphyrias
Alnylam shares crater after deaths force investigators to scrap PhIII RNAi drug
Endpoints
Wed, 10/5/16 - 05:19 pm
Alnylam
RNAi
clinical trials
Could Alnylam Pharmaceuticals Change Medicine as We Know It?
Motley Fool
Tue, 05/31/16 - 09:16 am
Alnylam
RNAi
Sanofi steps deeper into RNAi work, opts in on Alnylam hemophilia drug
Fierce Biotech
Fri, 10/2/15 - 04:53 pm
Sanofi
RNAi
Alnylam
ALN-AT3
Genzyme Sanofi
hemophilia
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »